-
Funding the future: Focusing on excellence through endowments
Earlier detection. Better treatments. More time with loved ones. Breakthroughs in cancer care don’t happen by chance—they’re driven by exceptional faculty pursuing bold ideas.
-
Micki and Steven Hirsch
Clinical trials are considered essential for groundbreaking research. To help advance Dana-Farber Cancer Institute’s clinical trials, Micki and Steven Hirsch made a gift of $100,000 to the Hirsch Family Fund for the Office of Clinical Research. Jeffrey Meyerhardt, MD, MPH, FASCO, leads the program which has benefited from the generous support of the Hirsch fund…
-
The Dana-Farber Society
The Dana-Farber Society (DFS) is a group of visionary donors who are changing lives and creating a legacy through a planned gift such as a bequest, life income gift, or beneficiary designation to Dana-Farber Cancer Institute, the Jimmy Fund, the Friends of Dana-Farber, or the Pan-Mass Challenge.
-
Dana-Farber faculty are part of “grand challenge” to defeat childhood tumors
Dana-Farber has been awarded more than $3 million in funding as part of a Cancer Grand Challenge to find new treatments for solid tumors in children.
-
Janower family drives pediatric brain tumor research forward
Cindy and AJ Janower’s introduction to the challenging world of childhood cancer began when their daughter, Samantha “Sammi,” was just three years old.
-
Breast Cancer Research Foundation grants more than $4 million to speed Dana-Farber research
Building on past support, BCRF recently made grants totaling more than $4 million to 12 physician-scientists at Dana-Farber.
-
Beerman Family Fund fuels next-generation approach to cancer vaccines
Gift may help speed production, reduce cost, and increase personalization of cancer vaccines to be more effective in many types of cancers.
-
Kesslers expedite research to expand treatment options for AML
A crucial infusion of funds from Michele and Howard Kessler is enabling the clinical trial of a promising combination treatment.
-
Expect Miracles celebrates milestones in another million dollar year
Expect Miracles Foundation's support for innovative drug development at Dana-Farber surpassed $15 million in 2024.
-
National Cancer Center
National Cancer Center awarded fellowship grants to Dana-Farber totaling $328,000. One new grant will support Katharina Hoebel, MD, PhD, in developing personalized treatment for non-small cell lung cancer through the use of artificial intelligence. With a second new commitment, Diego Martinez Alonso, PhD, will explore how to utilize CDK4/6 inhibitors as anticancer drugs.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.